Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yiqi Joint Venture
- Development stage
- Preclinical
- Lead developer
- The Affiliated Hospital of Shandong University of Traditional Chinese Medicine
- Administration
- Oral (inferred From Typical Tcm Administration)
01
Overview
Yiqi Joint Venture refers to a traditional Chinese medicine (TCM) formulation used in clinical settings, notably in combination with minimally invasive debridement for the treatment of granulomatous lobular mastitis. The specific herbal composition and mechanism of action are not detailed in available sources, but as a TCM product, it likely contains multiple herbal ingredients aimed at modulating immune response and promoting tissue healing. The therapy is being studied for its effectiveness on disease duration, recurrence rate, patient satisfaction after cure, ultrasound imaging outcomes, conservative treatment efficacy, surgical methods employed, laboratory findings, breast symptoms improvement, and aesthetic results post-treatment[1]. There is no evidence that "Yiqi Joint Venture" refers to a single pharmaceutical ingredient or an internationally recognized drug entity.
- Other names
- Yiqi Joint Venture Traditional Chinese Medicine
Beyond the preview
Go deeper on Yiqi Joint Venture.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yiqi Joint Venture.